Staphylococcus capitis: Review of Its Role in Infections and Outbreaks

V Heath, E Cloutman-Green, S Watkin, M Karlikowska… - Antibiotics, 2023 - mdpi.com
In June 2021, a national incident team was formed due to an increased detection of
Staphylococcus capitis in samples from hospitalised infants. Staphylococcus capitis has …

Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants

OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …

Therapeutic options and outcomes for the treatment of children with gram-positive bacteria with resistances of concern: A systematic review

L Chiusaroli, C Liberati, L Rulli, E Barbieri, M De Pieri… - Antibiotics, 2023 - mdpi.com
Background: Methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant
coagulase-negative Staphylococci (MR-CoNS), and vancomycin-resistant Enterococci …

Daptomycin use for persistent coagulase-negative staphylococcal bacteremia in a neonatal intensive care unit

E Papachatzi, D Gkentzi, S Tzifas, T Dassios… - Antibiotics, 2024 - mdpi.com
During the last two decades, the incidence of late-onset sepsis (LOS) has increased due to
improved survival of premature neonates. Persistent bacteremia (PB) in LOS is defined as …

Incidence of healthcare-associated infections in a neonatal intensive care unit before and during the COVID-19 pandemic: a four-year retrospective cohort study

M Ceparano, A Sciurti, C Isonne, V Baccolini… - Journal of Clinical …, 2023 - mdpi.com
The COVID-19 pandemic may have had an impact on healthcare-associated infection (HAI)
rates. In this study, we analyzed the occurrence of HAIs in a neonatal intensive care unit …

Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia

AS Haynes, H Maples, S Parker - Journal of the Pediatric …, 2023 - academic.oup.com
Vancomycin remains the standard of care for treating methicillin-resistant Staphylococcus
aureus (MRSA) bacteremia in pediatrics largely because no alternative antibiotic is …

Neonatal bloodstream infections

BR Hadfield, JB Cantey - Current Opinion in Infectious Diseases, 2021 - journals.lww.com
Neonatal BSIs continue to decrease due to enhanced infection control and prevention
techniques. However, many challenges remain, including emerging bacterial and fungal …

Safety and treatment outcomes of infants and children treated with daptomycin: Six-year experience from a pediatric academic medical center

BJ Vonasek, AM Samuel, SL Henderson… - Clinical …, 2025 - journals.sagepub.com
Daptomycin is a common treatment for serious infections caused by gram-positive bacteria
in adult patients; however, data regarding its safety and efficacy in the pediatric population …

Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives

C Minotti, I Zuccon, E Priante, L Bonadies, C Di Chiara… - Children, 2022 - mdpi.com
With a considerable morbidity and mortality burden, infective endocarditis still represents a
challenge for clinicians. This is a case of persistent Staphylococcus epidermidis endocarditis …

Ventriculitis and meningitis: by methicillin-resistant S. epidermidis: comparison of serum and CSF vancomycin concentrations and possible effect on MIC

C Sette, A Parodi, S Barco… - Journal of …, 2022 - Taylor & Francis
A case of HCAMV due to methicillin-resistant S. epidermidis (MRSE) in a new-born treated
with vancomycin is described. Despite adequate vancomycin serum concentrations, an …